Patents by Inventor Jacob De Haan

Jacob De Haan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7521247
    Abstract: A cartridge for monitoring the function of a device for blood platelet diagnosis has a housing which includes a test chamber and a holding chamber. A fluid volume of a test fluid is present inside the holding chamber. An air cushion is arranged above the fluid volume. A measurement cell, which has a capillary tube, is fitted in the upper part of the test chamber.
    Type: Grant
    Filed: December 22, 2004
    Date of Patent: April 21, 2009
    Assignee: Siemens Healthcare Diagnostics Products GmbH
    Inventor: Jacob De Haan
  • Publication number: 20050136541
    Abstract: A cartridge for monitoring the function of a device for blood platelet diagnosis has a housing 1 which includes a test chamber 3 and a holding chamber 5. A fluid volume 7 of a test fluid 4 is present inside the holding chamber 5. An air cushion 6 is arranged above the fluid volume 7. A measurement cell 8, which has a capillary tube 9, is fitted in the upper part of the test chamber 3.
    Type: Application
    Filed: December 22, 2004
    Publication date: June 23, 2005
    Inventor: Jacob De Haan
  • Patent number: 6087120
    Abstract: A process for determining complement activation due to contact between a biomaterial and a complement system, by incubating in vitro the biomaterial with the complement system and determining the formation of a complement convertase by using a substrate of the complement convertase and detecting substrate cleavage. The biomaterial after said incubation with the complement system may be separated therefrom and formation of a complement convertase may be determined with the separated biomaterial, the separated complement system, or both. The complement convertase may be Factor B convertase, C3 convertase or C5 convertase, and the substrate may be a labeled oligopeptide comprising an amino acid sequence corresponding to the cleavage site of the complement convertase. Suitable labels are dyes, fluorochromes, radioactive atoms or groups, and enzymes. Either classical or alternative pathway complement activation, or both, are determined.
    Type: Grant
    Filed: March 8, 1999
    Date of Patent: July 11, 2000
    Assignee: HaemoProbe B.V.
    Inventors: Willem Van Oeveren, Jacob De Haan